Related by context. Frequent words. (Click for all words.) 78 phase IIa 77 Phase Ib 77 phase IIb 76 Phase 2a trial 75 Phase 1b 74 dose escalation trial 74 Phase 2a 74 Phase 1b clinical 74 Phase 1a 73 Phase 2a clinical 73 phase 2a 73 Phase 2b study 73 Phase 2b trial 73 Phase IIa trial 72 Phase 1b trial 72 Phase IIa 71 Phase III 70 Phase Ia 70 Phase IIa clinical 70 Phase III clinical 69 HGS ETR1 69 Phase II 69 dose escalation 69 Phase 2b clinical 69 axitinib 69 Phase IIb 69 BAY #-# 69 blinded placebo controlled 69 Phenoptin 68 confirmatory Phase III 68 randomized Phase III 68 Phase IIb trial 68 PXD# 68 multiple ascending dose 68 dose escalation study 68 Phase IIb clinical 68 IMC A# 68 Phase III pivotal 68 dose cohorts 67 Phase 2b 67 placebo controlled randomized 67 Phase III randomized 67 RG# [001] 67 tolerated dose MTD 67 SCH # 67 OXi# 66 IIa clinical trial 66 PF # [001] 66 randomized Phase 66 pivotal Phase III 66 label dose escalation 66 ASA# 66 CA4P 65 clinical trial 65 Phase 65 pivotal Phase 65 active comparator 65 HuMax CD# 65 ofatumumab 65 pharmacokinetic studies 64 Pharmacokinetic 64 multicenter randomized 64 CoFactor 64 AP# [003] 64 ocrelizumab 64 Mylotarg 64 valopicitabine 64 nitazoxanide 64 Phase III clinical trials 64 TELCYTA 64 temsirolimus 64 eltrombopag 64 Phase III trials 64 vicriviroc 64 rNAPc2 64 IMGN# 64 confirmatory Phase 3 64 tocilizumab 64 multicentre 64 orally bioavailable 64 methylnaltrexone 64 MGCD# [001] 63 placebo controlled 63 alvimopan 63 tolerability 63 BCX# 63 relapsed multiple myeloma 63 randomized placebo controlled 63 multicenter randomized double 63 single ascending dose 63 PEG Interferon lambda 63 pharmacodynamic 63 pharmacokinetic 63 blind randomized placebo 63 PRX # 63 Phase III Trial 63 carfilzomib 63 sunitinib 63 Amigal 63 randomized controlled clinical 63 dose regimens